PMID: 7013592Mar 1, 1981Paper

Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects

Annals of Internal Medicine
R J GrafD Porte

Abstract

The influence of therapy of hyperglycemia on the progression of diabetic neuropathy is unclear. We studied variables of glycemia and motor and sensory nerve conduction velocity in a group of 18 non-insulin-dependent diabetic subjects before and after institution of diabetes therapy. Diabetes therapy significantly reduced variables of glycemia after 1, 3, 6, and 12 months. Conduction velocity of the median motor nerve was improved from baseline at each time tested during treatment. In addition, peroneal and tibial motor nerve conduction velocities improved in patients whose levels of hyperglycemia were lowered. Moreover, extent of improvement of conduction velocity of some motor nerves was related to the degree of reduction of hyperglycemia. Sensory nerve conduction velocity was not altered by diabetes therapy. These findings support the hypothesis of a metabolic component to diabetic neuropathy and suggest that optimal glycemic control may be beneficial to patients with this disorder.

Citations

Oct 1, 1993·Diabetes/metabolism Reviews·D A GreeneS A Lattimer
Jul 1, 1983·Acta diabetologica latina·G CrepaldiG Pagano
Jan 1, 1986·Acta diabetologica latina·G ComiG Chiumello
Jul 1, 1986·Journal of General Internal Medicine·J D GoodsonD M Nathan
Oct 1, 1985·Irish Journal of Medical Science·P M BellD R Hadden
Dec 1, 1987·Journal of the Neurological Sciences·P J HaugC Q Edwards
Jan 1, 1988·Diabetes Research and Clinical Practice·C Liniger
Oct 24, 1994·Neuroscience Letters·C A DelaneyR A Westerman
Jul 19, 2003·Metabolism: Clinical and Experimental·P ValensiUNKNOWN French Group for Research and Study of Diabetic Neuropathy
Jan 20, 1983·The New England Journal of Medicine·R G JudzewitschD Porte
Jan 20, 1983·The New England Journal of Medicine·A I WinegradD B Martin
Jun 11, 1992·Annals of Surgery·T J WiemanH C Polk
Apr 7, 2007·Annals of Plastic Surgery·Can KopalMustafa Sengezer
Dec 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·M T DentR M Wilson
Dec 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·M HallettA Berardelli
Nov 1, 1986·Clinics in Endocrinology and Metabolism·K R GillonP K Thomas
Sep 14, 1999·The American Journal of Medicine·G J Parry
Jan 22, 2005·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Yuriko KikkawaTakamichi Hattori
Nov 15, 1985·The American Journal of Medicine·M A Pfeifer
Nov 1, 1989·Acta Neurologica Scandinavica·F MeliB Fierro
Aug 1, 1988·Acta Neurologica Scandinavica·S H SindrupE H Sindrup
Jun 14, 2001·The Urologic Clinics of North America·A Nehra, R B Moreland
May 21, 2013·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Ria ArnoldArun V Krishnan
Dec 3, 2014·The Medical Clinics of North America·Matthew P Gilbert
Dec 30, 2006·Muscle & Nerve·Arun V Krishnan, Matthew C Kiernan
Jan 1, 1981·The American Journal of Medicine·D PorteE Halar
Aug 1, 1984·Annals of Neurology·W TroniI Rainero
Jan 1, 1984·Annals of Neurology·M J Brown, A K Asbury
Feb 1, 1996·The Tohoku Journal of Experimental Medicine·Y FujimuraK Murata
Mar 11, 2005·Brain : a Journal of Neurology·Arun V Krishnan, Matthew C Kiernan
May 1, 1988·Diabetes/metabolism Reviews·H Genovely, M A Pfeifer
May 1, 1988·Diabetes/metabolism Reviews·A Vinik, B Mitchell
May 1, 1988·Diabetes/metabolism Reviews·D A GreeneA A Sima
Dec 19, 1998·Acta Neurologica Scandinavica·J ToviP Engfeldt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.